How Does GLP-1 Work for Weight Loss, and How Long Does It Take?
Semaglutide is a GLP-1 receptor agonist that reduces hunger, increases fullness and slows gastric emptying — but it works on a schedule, not on demand. The dose is escalated over 16 weeks, and the largest trial showed weight loss continuing for more than a year before levelling off. This guide explains the mechanism, the dose ladder, and a realistic timeline. [1]
Check your eligibility →
How Does Semaglutide Work for Weight Loss?
Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a hormone the gut releases after eating, and acts on appetite-regulating centres in the brain to reduce hunger and increase fullness. It also slows gastric emptying and improves insulin and glucagon responses. The result: you eat less, feel satisfied sooner, and sustain a calorie deficit without extreme restriction.
Rather than simply suppressing appetite, semaglutide works with the body's own appetite-regulating system. That distinction matters, because it explains why most people describe the experience as food becoming less interesting rather than as forcing themselves to go hungry. [5]
Because semaglutide reduces appetite so effectively, it becomes structurally harder to eat enough protein. That is the central nutritional problem of GLP-1 therapy — and it must be solved deliberately. See our macro ratio guide.
What Is the Semaglutide Dose Schedule?
Semaglutide for weight management follows a five-step, 16-week escalation. You start at 0.25 mg once weekly for 4 weeks, then step up every 4 weeks through 0.5 mg, 1.0 mg and 1.7 mg, reaching the 2.4 mg maintenance dose from around week 17. The 0.25 mg starting dose is an adaptation dose — it is not expected to produce meaningful weight loss on its own.
1–4
5–8
9–12
13–16
Maintenance
The titration exists for one reason: tolerability. Escalating slowly gives the gastrointestinal tract time to adapt to GLP-1 receptor activation, which substantially reduces the frequency and severity of nausea, vomiting and diarrhoea. [2]
| Weeks | Weekly dose | Clinical purpose | What you may notice |
|---|---|---|---|
| 1–4 | 0.25 mg | Adaptation — not a therapeutic dose | Appetite starts to change; weight loss usually modest |
| 5–8 | 0.5 mg | First step up | Appetite control becomes more noticeable |
| 9–12 | 1.0 mg | Continued escalation as tolerated | More consistent weight loss for many |
| 13–16 | 1.7 mg | Approaching therapeutic range | Stronger satiety; fewer cravings |
| 17+ | 2.4 mg | Standard maintenance dose | Full therapeutic effect for chronic weight management |
Higher-dose and oral semaglutide formulations have been approved in some markets. Availability and licensing differ by country — your Karespot prescriber will confirm what is appropriate and available for you.
Never escalate, skip, or stop your dose on your own, and never combine semaglutide with another GLP-1 medicine. Dose decisions belong with your prescriber. See also: Mounjaro doses — what to expect at each stage.
How Long Does It Take for Semaglutide to Start Working?
Semaglutide begins acting within days, but visible weight loss takes weeks. In the STEP-1 trial, weight loss was measurable from the first assessment at week 4 and continued steadily, reaching a nadir at week 60 and a mean reduction of −14.9% of body weight at week 68 versus −2.4% on placebo. Because the dose ladder takes 16 weeks, expect the first three to four months to be a build-up phase.
Schematic representation of the reported trajectory. Endpoint values (−14.9% vs −2.4% at week 68) and the week-60 nadir are as published. Source: Wilding JPH et al., N Engl J Med. 2021. [1]
"In the semaglutide group, weight loss was observed from the first postrandomization assessment (week 4) onward, reaching a nadir at week 60."
Wilding JPH et al. N Engl J Med. 2021 — the STEP-1 trial. [1]
This single sentence reframes most plateau anxiety. The flattening of the curve is not a failure of the drug — it is the curve the drug produces. If you are 12 to 15 months into treatment and your weight has stabilised, you have most likely arrived at the outcome the trials predict, not run into a problem.
What Should You Expect Month by Month?
Expect appetite change first and scale change second. Weeks 1–4 bring reduced hunger with modest weight loss; weeks 5–16 cover dose escalation with steadily increasing results; months 6–15 are the steepest sustained phase; and beyond roughly 15 months the goal shifts from losing weight to maintaining it.
What Does the Evidence Actually Show?
Across the STEP programme, semaglutide 2.4 mg produced mean weight loss of roughly 15–17% over 68 weeks, sustained to 15.2% at two years. Adding intensive behavioural therapy improved results further, and withdrawing treatment reversed them — participants regained about two-thirds of lost weight within a year of stopping.
| Trial | Design | Duration | Key result |
|---|---|---|---|
|
STEP-1 NEJM 2021 |
1,961 adults, semaglutide 2.4 mg vs placebo + lifestyle | 68 weeks | −14.9% vs −2.4% placebo. 86.4% lost ≥5%. Nadir at week 60. [1] |
|
STEP-4 JAMA 2021 |
Withdrawal design — continue vs switch to placebo at week 20 | 68 weeks | Continued: −17.4% total, plateauing weeks 60–68. Switched to placebo: steady regain. [3] |
|
STEP-5 Nat Med 2022 |
304 adults, two-year continued treatment | 104 weeks | −15.2% vs −2.6% placebo — results sustained, not lost. [4] |
|
STEP-1 extension Diabetes Obes Metab 2022 |
Observational follow-up after treatment stopped | +52 weeks off-drug | Participants regained ≈ two-thirds of lost weight within a year; cardiometabolic gains reverted. [6] |
Individual results vary considerably. These are trial means, not promises.
The STEP-1 extension is the most important trial for anyone considering stopping. Obesity behaves as a chronic, relapsing condition — like hypertension, it responds to treatment rather than being cured by it. At Karespot, we plan for maintenance from the first consultation, not as an afterthought.
Why Doesn't Semaglutide Work the Same for Everyone?
Response varies because weight regulation is multifactorial. Starting body weight, age, genetics, body composition, hormone levels, sleep, stress, other medications and adherence all shape outcomes. In STEP-1, 86.4% of participants lost at least 5% of body weight — a strong majority, but not everyone, and not at the same rate.
One factor is more modifiable than the rest: what you lose. Across GLP-1 trials, lean soft tissue has accounted for roughly 26–40% of total weight lost. Muscle is metabolically active, so losing it lowers your resting metabolic rate — which makes further weight loss harder and plateaus more stubborn. [7]
This is substantially preventable. Adequate protein — evidence supports 1.6–2.2 g per kg of body weight per day during active fat loss — combined with resistance training two to three times weekly is consistently associated with preserved lean mass during treatment. [8]
- Calculate your target with the Karespot Protein Calculator — appetite suppression makes under-eating protein very easy.
- Anchor every meal around a protein source: chicken, fish, eggs, dairy, paneer, tofu, dal, rajma, chickpeas.
- Add resistance training 2–3× weekly. No gym required — see how to start exercising when you're out of shape.
- Recalculate your energy needs as you lose weight using the BMR & TDEE guide.
A flat scale with a shrinking waist and preserved strength is a better clinical outcome than a rapidly falling scale with muscle loss. Track body composition, not just weight.
Starting semaglutide, or unsure if it's working?
Every Karespot patient is assessed and supervised by a registered MBBS + MD (Internal Medicine) prescriber, with a dietician, clinical psychologist and health coach alongside. Dosing, side effects and progress reviews are managed at every stage.
Check Your Eligibility → Explore more guides on Kare Hub →Frequently Asked Questions
How long does it take for semaglutide to start working for weight loss?
How much weight can you lose on semaglutide?
Why is my first semaglutide dose so low?
Why has my weight loss on semaglutide slowed down?
Does semaglutide keep working after the first year?
What happens if I stop taking semaglutide?
Does semaglutide cause muscle loss?
Can I lose fat even if the scale isn't moving?
Should I increase my dose if I'm not losing weight?
Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
doi.org/10.1056/NEJMoa2032183Novo Nordisk. WEGOVY (semaglutide) injection — Prescribing Information. US Food and Drug Administration. 2023.
accessdata.fda.gov — Wegovy Prescribing InformationRubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425.
doi.org/10.1001/jama.2021.3224Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28:2083–2091.
doi.org/10.1038/s41591-022-02026-4Endocrine Society of India. ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India — An Update. Indian J Endocrinol Metab. 2025;29(4):355–365.
doi.org/10.4103/ijem.ijem_680_25Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–1564.
doi.org/10.1111/dom.14725GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity: a systematic review and meta-analysis. Int J Obes. 2026.
doi.org/10.1038/s41366-026-02088-1Leidy HJ, Clifton PM, Astrup A, et al. The Role of Protein in Weight Loss and Maintenance. Am J Clin Nutr. 2015;101(6):1320S–1329S.
doi.org/10.3945/ajcn.114.084038Moon J, Koh G. Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss. J Obes Metab Syndr. 2020;29(3):166–173.
doi.org/10.7570/jomes20028Karespot. GLP-1 Support Programme — Holistic Weight Management.
karespot.in/products/glp-1-support-programKarespot. Understanding Macronutrients: What's the Best Macro Ratio for Weight Loss on GLP-1? Kare Hub Blog, Jun 2026.
karespot.in — Macro Ratio GuideKarespot. Mounjaro Doses: What to Expect at Each Stage of Treatment. Kare Hub Blog, Jun 2026.
karespot.in — Mounjaro Dose GuideKarespot. Silencing Food Noise: How Medical Weight Loss Treatment Can Help. Kare Hub Blog, 2026.
karespot.in — Food Noise GuideKarespot. How to Calculate Your BMR and Use It for Weight Loss. Kare Hub Blog, 2026.
karespot.in — BMR GuideKarespot. Free Protein Calculator.
karespot.in/pages/protein-calculatorDr. Prakrati Garg is a Research Associate and published researcher in Biotechnology at Shoolini University, and Content Strategist at Karespot. With expertise in herbal drug development, nanotechnology, and drug delivery systems, she brings a rigorous scientific approach to Karespot's health and wellness content.
Dr. Sana Umar is an Assistant Professor at Doon Medical College and Medical Reviewer at Karespot. A Clinical Pathologist with FRCP credentials and NMC registration (UKMC Reg. 8506), she ensures all clinical content aligns with current prescribing guidelines and evidence-based best practices in GLP-1 therapy and weight management medicine.
Weight loss and lifestyle change can feel like a lonely road. At Karespot, we believe you should never have to walk it alone.
Karespot is a telehealth platform that connects patients across India with a team of MBBS + MD (Internal Medicine) specialists and Endocrinologists who provide personalised, medically supervised care. We believe that medication is a tool, not the answer alone. Real, lasting change comes from building the habits and lifestyle that carry you forward long after treatment ends.
Every Karespot patient is supported by a holistic team: a doctor who understands your metabolic health, a registered dietician who adapts your nutrition to your real life, a clinical psychologist who helps you understand your relationship with food, and a lifestyle health coach who helps you build the daily habits that last.
Delhi & NCR: New Delhi, Noida, Gurugram, Faridabad, Ghaziabad
Uttarakhand: Dehradun, Haridwar, Roorkee, Haldwani, Rudrapur, Rishikesh, Nainital, Kotdwar
Uttar Pradesh: Lucknow, Kanpur, Agra, Varanasi, Prayagraj, Meerut, Gorakhpur, Aligarh, Bareilly
Maharashtra: Mumbai, Pune, Nagpur, Nashik, Thane, Navi Mumbai, Aurangabad
Karnataka: Bengaluru, Mysuru, Mangaluru, Hubballi-Dharwad, Belagavi
Telangana: Hyderabad, Warangal, Nizamabad, Karimnagar
Punjab & Chandigarh: Amritsar, Ludhiana, Jalandhar, Patiala, Chandigarh, Mohali
Other Cities: Chennai, Kolkata, Ahmedabad, Jaipur, Surat, Kochi, Indore, Coimbatore, Bhopal, Visakhapatnam, Thiruvananthapuram
Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Semaglutide is a prescription medicine that must be prescribed and supervised by a qualified Internal Medicine specialist or Endocrinologist. Never start, stop, or adjust your dose without consulting your Karespot doctor.
